微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 15.41% | 5.33% | 41.51% | 3/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 10.89% | 8.47% | 95.51% | 5/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 5.57% | 85.67% | -67.37% | 8/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 17.07% | 100.35% | 16.68% | 8/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 14.63% | 209.96% | 45.72% | 10/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 10.04% | 350.22% | 234.67% | 7/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3% | 175.23% | -64.79% | 35/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.52% | 91.03% | 80.51% | 37/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.72% | 61.64% | 111.66% | 74/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.23% | 253.97% | 104.59% | 79/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.09% | 23.86% | -75.56% | 85/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.46% | -38.4% | 52.74% | 77/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.92% | -47.2% | 363.49% | 86/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.63% | -85.04% | -28.41% | 106/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.88% | -77.2% | -87.85% | 96/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.24% | -31.11% | 30.92% | 64/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 5.53% | 41.43% | 31.35% | 73/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.21% | 16.3% | 9.07% | 66/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.86% | 467.65% | -63.27% | 22/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.51% | 98.68% | 190.33% | 49/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 3.62% | 52.74% | -31.57% | 67/158 | 4.23% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 5.29% | 16.78% | 35.29% | 83/158 | 2.57% | 河化股份 | 45.32% | 行业排名> |
| 2019-09-30 | 3.91% | -56.07% | 64.98% | 77/158 | 7.53% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 2.37% | -70.08% | 248.53% | 77/158 | 5% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-03-31 | 0.68% | 288.89% | -84.99% | 89/158 | 2.43% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 4.53% | -68.74% | -49.1% | 90/158 | 7.17% | 奥赛康 | 28.15% | 行业排名> |
| 2018-09-30 | 8.9% | 2% | 12.37% | 32/158 | 7.21% | 宏源药业 | 21.91% | 行业排名> |
| 2018-06-30 | 7.92% | 115.8% | 2300% | 15/158 | 4.64% | 奥赛康 | 9.7% | 行业排名> |
| 2018-03-31 | -0.36% | 2% | -102.48% | 94/158 | 2.55% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 14.49% | 116.16% | 294.82% | 28/158 | 9.68% | 信立泰 | 25.93% | 行业排名> |
| 2017-06-30 | 3.67% | 113.93% | 104.09% | 65/158 | 5.62% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | -89.67% | 2% | -240.3% | 110/158 | 6.22% | 奥赛康 | 12.08% | 行业排名> |
| 2016-06-30 | -26.35% | 2% | 2% | 88/158 | 3.52% | 一品红 | 31.62% | 行业排名> |